Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Empathy in PTSD
NCT01325168Phase 4Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Aug 2011
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoints: Computer tasks assessing emotional and cognitive empathy and Relationship between empathic abilities and autobiographical memory retrieval. Started Aug 2011; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01325168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325168.